Company page
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. is a public company traded under the ticker FATE in the American market. The company has a market capitalization of approximately $243.6 million. Fate Therapeutics focuses on developing cellular immunotherapies for cancer and immune disorders.
- Ticker
- FATE:NASDAQ
- Asset type
- Stock
- Market cap
- $243.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD